In another study, Reddy group (Kandimalla et al. 2016) [33] investigated whether a partial reduction of Drp1 protect neurons from phosphorylated Tau-induced mitochondrial and synaptic toxicities in AD progression [33]. Here, MAPT is linked to Alzheimer disease.